Since TNF is a major proinflammatory cytokine in inflammatory bowel disease (IBD), a chronic immune-inflammatory disease of the gastrointestinal tract, anti-TNF therapy is effective in a proportion of patients. The gene discussed is TNF; the disease is inflammatory bowel disease.